The Global Action Network for Sickle Cell and Other Inherited Blood
Disorders (GANSID) is pleased to announce that the GANSID Congress 2026 will be held from
October 23–25, 2026, at HICC, Novotel, in collaboration with GANSID, USA, and hosted by the
Thalassemia and Sickle Cell Society (TSCS), Hyderabad, serving as local partner.

The Congress will bring together hundreds of renowned national and international speakers, leading
clinicians, researchers, laboratory and translational scientists, patient organizations, industry
partners, policymakers, and global health agencies to share the latest advances, research, and best
practices in the field of inherited blood disorders.

This years theme, "From Innovation to Implementation: Bridging Science and Access in Inherited
Blood Disorders," reflects the Congress s commitment to translating scientific progress into real
world impact for patients and communities worldwide.

Spanning three days, the program includes plenary sessions, abstract and poster presentations,
industry symposia, early career and mid late career sessions, patient engagement sessions, a
presentation theatre, and dedicated networking opportunities, including an opening ceremony and a
networking reception.

Speaking about the event Dr. Chandrakanth Agarwal, President, TSCS said, “Hyderabad hosting such
a prestigious event is a remarkable opportunity for the community. We warmly invite all participants
to attend this prestigious conference, attend the scientific sessions, interact with experts, and benefit
from this exceptional learning and networking opportunity.”

Participants can look forward to scientific sessions, expert interactions, and networking
opportunities with leading voices from around the world in the space of sickle cell disease and
related disorders.